Literature DB >> 11781262

Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells.

James A L Fenton1, Jan-Willem Vaandrager, Wilhelmina M Aarts, Richard J Bende, Karel Heering, Martin van Dijk, Gareth Morgan, Carel J M van Noesel, Ed Schuuring, Philip M Kluin.   

Abstract

With the use of DNA-fiber fluorescent in situ hybridization, a BCL2 protein positive follicular lymphoma with a novel BCL2 breakpoint involving the immunoglobulin heavy chain (IGH) switch mu (S(mu)) region instead of the J(H) or D(H) gene segments was identified. Sequence analysis showed that the genomic breakpoint is localized between the S(mu) region of the IGH complex and the first intron of BCL2. Reverse-transcriptase polymerase chain reaction showed expression of a unique hybrid IGH-BCL2 transcript involving the transcription initiation site I(mu). Sequence analysis of the V(H) region of the functional nontranslocated IGH allele showed multiple shared somatic mutations but also a high intraclonal variation (53 differences in 15 clones), compatible with the lymphoma cells staying in or re-entering the germinal center. This is the first example of a t(14;18) translocation that results from an illegitimate IGH class-switch recombination during the germinal center B-cell stage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11781262     DOI: 10.1182/blood.v99.2.716

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination.

Authors:  P L Roddam; S Rollinson; M O'Driscoll; P A Jeggo; A Jack; G J Morgan
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

2.  Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features.

Authors:  Oscar Krijgsman; Patricia Gonzalez; Olga Balagué Ponz; Margaretha G M Roemer; Stefanie Slot; Annegien Broeks; Linde Braaf; Ron M Kerkhoven; Freek Bot; Krijn van Groningen; Max Beijert; Bauke Ylstra; Daphne de Jong
Journal:  Haematologica       Date:  2013-07-12       Impact factor: 9.941

Review 3.  Best Practice No 185. Cytological and molecular diagnosis of lymphoma.

Authors:  G Kocjan
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

4.  In situ analysis of the variable heavy chain gene of an IgM/IgG-expressing follicular lymphoma: evidence for interfollicular trafficking of tumor cells.

Authors:  Wilhelmina M Aarts; Richard J Bende; Jan-Willem Vaandrager; Philip M Kluin; Anton W Langerak; Steven T Pals; Carel J M van Noesel
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

Review 5.  Lymphoma stem cells: enough evidence to support their existence?

Authors:  Jose A Martinez-Climent; Lorena Fontan; Randy D Gascoyne; Reiner Siebert; Felipe Prosper
Journal:  Haematologica       Date:  2010-02       Impact factor: 9.941

6.  Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma.

Authors:  E Paszkiewicz-Kozik; J Kulik; A Fabisiewicz; A Tysarowski; E Kraszewska; J A Siedlecki; J Walewski
Journal:  Med Oncol       Date:  2008-05-10       Impact factor: 3.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.